BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17236396)

  • 1. Effect of blood collection tube types on the measurement of human epidermal growth factor.
    Yucel A; Karakus R; Cemalettin A
    J Immunoassay Immunochem; 2007; 28(1):47-60. PubMed ID: 17236396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some properties of human epidermal growth factor (hEGF)-like immunoreactive material originating from platelets during blood coagulation.
    Kurobe M; Tokida N; Furukawa S; Hayashi K
    Biochem Int; 1986 Nov; 13(5):729-33. PubMed ID: 3545207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular nature of human epidermal growth factor (hEGF)-like immunoreactivity in human plasma.
    Kurobe M; Furukawa S; Hayashi K
    Biochem Int; 1986 May; 12(5):677-83. PubMed ID: 3524570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.
    Oka Y; Orth DN
    J Clin Invest; 1983 Jul; 72(1):249-59. PubMed ID: 6603475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8-11 years.
    Nilsson TK; Boman K; Jansson JH; Thøgersen AM; Berggren M; Broberg A; Granlund A
    Thromb Res; 2005; 116(3):249-54. PubMed ID: 15935834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human epidermal growth factor in human serum and urine under native conditions.
    Aybay C; Karakus R; Yucel A
    Cytokine; 2006 Jul; 35(1-2):36-43. PubMed ID: 16908178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K; Hudgins WR
    Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices.
    Mannello F; Tanus-Santos JE; Meschiari CA; Tonti GA
    Anal Biochem; 2008 Mar; 374(1):56-63. PubMed ID: 18082127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor in human seminal plasma.
    Hirata Y; Uchihashi M; Hazama M; Fujita T
    Horm Metab Res; 1987 Jan; 19(1):35-7. PubMed ID: 3493966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of organochlorine levels in postprandial serum or in blood collected in serum separator tubes.
    Longnecker MP; Bernstein L; Bird CL; Yancey AK; Peterson JC
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):753-5. PubMed ID: 8877068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant differences in prothrombin time and INR values related to blood sample collection in plastic vs glass tubes.
    Fiebig EW; Etzell JE; Ng VL
    Am J Clin Pathol; 2005 Dec; 124(6):902-9. PubMed ID: 16416740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditions.
    Marquet P; Sauvage FL; Loustaud-Ratti V; Babany G; Rousseau A; Lachâtre G
    Ther Drug Monit; 2010 Apr; 32(2):237-41. PubMed ID: 20216114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
    Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN
    Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive two-site enzyme immunoassay for human epidermal growth factor (urogastrone).
    Hayashi K; Nomoto H; Kurobe M; Nishimuro S; Hiratani H; Furukawa S
    Biochem Int; 1985 Jun; 10(6):839-45. PubMed ID: 3899115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
    Toulon P; Ajzenberg N; Smahi M; Guillin MC
    Thromb Res; 2007; 119(2):135-43. PubMed ID: 16426667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the blood-collection tube material and long-term storage on platelet activation parameters on the ADVIA 120/2120 hematology system.
    Van Cott EM; Fletcher SR; Kratz A
    Lab Hematol; 2005; 11(1):71-5. PubMed ID: 15790555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a sensitive enzyme immunoassay for human epidermal growth factor (urogastrone).
    Kurobe M; Tokida N; Furukawa S; Ishikawa E; Hayashi K
    Clin Chim Acta; 1986 Apr; 156(1):51-9. PubMed ID: 3516461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?
    Lee JK; Hong YJ; Han CJ; Hwang DY; Hong SI
    Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the relationship between white lesion of vulva and human epidermal growth factor].
    Chang J; He W; Zhang J
    Zhonghua Fu Chan Ke Za Zhi; 1995 Apr; 30(4):209-11. PubMed ID: 7664605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.